Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0XM6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp for VYNDAMAX 61 mg capsules (30-count unit dose packages) on December 3, 2025, with completion expected by December 24, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The award is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and extends through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains for military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities under its DLA contract framework. Performance under this delivery order will occur at the company's Conshohocken facility. VYNDAMAX (dapagliflozin) is an FDA-approved medication used in diabetes and heart failure treatment, reflecting AmerisourceBergen's role in supplying specialized pharmaceutical products to support military and federal healthcare missions.
Quick answers
Who was awarded contract SPE2DR26F0XM6?
SPE2DR26F0XM6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F0XM6 worth?
The government has obligated $14,593 on SPE2DR26F0XM6.
Is contract SPE2DR26F0XM6 an order under another contract?
Yes. SPE2DR26F0XM6 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0XM6 competed?
The extent of competition for SPE2DR26F0XM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award